Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven D Pearson

Showing results (41-50 of 169) with videos related to

Pageof 17
Sort By:
Journal of Comparative Effectiveness Research|August 10, 2022
The next generation of rare disease drug policy: ensuring both innovation and affordabilityCaroline Pearson, Lindsey Schapiro, Steven D Pearson
Journal of General Internal Medicine|November 11, 2010
The diagnostic performance of multi-slice coronary computed tomographic angiography: a systematic reviewDaniel A Ollendorf, Michelle Kuba, Steven D Pearson
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 12, 2020
How Are Incremental Cost-Effectiveness, Contextual Considerations, and Other Benefits Viewed in Health Technology Assessment Recommendations in the United States?Logan Trenaman, Steven D Pearson, Jeffrey S Hoch
The Journal of Clinical Ethics|November 27, 2002
Caring for patients within a budget: physicians' tales from the front lines of managed careSteven D Pearson, James E Sabin, Tracey Hyams
JAMA|May 26, 2018
Value-Based Pricing and Patient Access for Specialty DrugsJames C Robinson, Scott Howell, Steven D Pearson
The New England Journal of Medicine|August 10, 2012
The ethics of early evidence--preparing for a possible breakthrough in Alzheimer's diseaseJustin Lowenthal, Sara Chandros Hull, Steven D Pearson
Archives of Internal Medicine|October 28, 2009
Going off-label without venturing off-course: evidence and ethical off-label prescribingEmily A Largent, Franklin G Miller, Steven D Pearson
JAMA|August 24, 2006
Medicare's requirement for research participation as a condition of coverage: is it ethical?Steven D Pearson, Franklin G Miller, Ezekiel J Emanuel
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 25, 2022
The Influence of US Drug Price Dynamics on Cost-Effectiveness Analyses of BiologicsStephen J Kogut, Jon D Campbell, Steven D Pearson
JAMA Internal Medicine|May 7, 2014
The comparative clinical effectiveness and value of simeprevir and sofosbuvir for chronic hepatitis C virus infectionDaniel A Ollendorf, Jeffrey A Tice, Steven D Pearson
Pageof 17

Showing results (41-50 of 169) with videos related to

Sort By:
Pageof 17
Journal of Comparative Effectiveness Research|August 10, 2022
The next generation of rare disease drug policy: ensuring both innovation and affordabilityCaroline Pearson, Lindsey Schapiro, Steven D Pearson
Journal of General Internal Medicine|November 11, 2010
The diagnostic performance of multi-slice coronary computed tomographic angiography: a systematic reviewDaniel A Ollendorf, Michelle Kuba, Steven D Pearson
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 12, 2020
How Are Incremental Cost-Effectiveness, Contextual Considerations, and Other Benefits Viewed in Health Technology Assessment Recommendations in the United States?Logan Trenaman, Steven D Pearson, Jeffrey S Hoch
The Journal of Clinical Ethics|November 27, 2002
Caring for patients within a budget: physicians' tales from the front lines of managed careSteven D Pearson, James E Sabin, Tracey Hyams
JAMA|May 26, 2018
Value-Based Pricing and Patient Access for Specialty DrugsJames C Robinson, Scott Howell, Steven D Pearson
The New England Journal of Medicine|August 10, 2012
The ethics of early evidence--preparing for a possible breakthrough in Alzheimer's diseaseJustin Lowenthal, Sara Chandros Hull, Steven D Pearson
Archives of Internal Medicine|October 28, 2009
Going off-label without venturing off-course: evidence and ethical off-label prescribingEmily A Largent, Franklin G Miller, Steven D Pearson
JAMA|August 24, 2006
Medicare's requirement for research participation as a condition of coverage: is it ethical?Steven D Pearson, Franklin G Miller, Ezekiel J Emanuel
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 25, 2022
The Influence of US Drug Price Dynamics on Cost-Effectiveness Analyses of BiologicsStephen J Kogut, Jon D Campbell, Steven D Pearson
JAMA Internal Medicine|May 7, 2014
The comparative clinical effectiveness and value of simeprevir and sofosbuvir for chronic hepatitis C virus infectionDaniel A Ollendorf, Jeffrey A Tice, Steven D Pearson
Pageof 17